These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 6518859)

  • 1. [Determination of urinary fibrinogen degradation product in the toxemia of pregnancy].
    Wu JS
    Zhonghua Fu Chan Ke Za Zhi; 1984 Jul; 19(3):132-5, 189. PubMed ID: 6518859
    [No Abstract]   [Full Text] [Related]  

  • 2. [Fibrin and fibrinogen degradation products and other urinary proteins during eclampsia].
    Weise M; Schwabe G; Neubüser D
    Minerva Med; 1979 Oct; 70(43):2945-9. PubMed ID: 492563
    [No Abstract]   [Full Text] [Related]  

  • 3. [Fibrin-fibrinogen degradation products in the urine during pregnancy and puerperium].
    Carozzi S; Molinelli G; Lamperi S
    Minerva Med; 1979 Oct; 70(43):2951-7. PubMed ID: 492564
    [No Abstract]   [Full Text] [Related]  

  • 4. Fibrinogen and fibrin splitting products and other proteins in the urine during eclampsia.
    Weise M; Schwabe G; Neubüser D
    Panminerva Med; 1977; 19(6):401-5. PubMed ID: 609474
    [No Abstract]   [Full Text] [Related]  

  • 5. Significance of fibrin-degradation products (F.D.P.) determinations in human glomerulopathies.
    Dewan R; Ahooja P; Rizvi SN; Gulati PD
    J Assoc Physicians India; 1978 Jul; 26(7):605-12. PubMed ID: 721767
    [No Abstract]   [Full Text] [Related]  

  • 6. Serum and urinary fibrin/fibrinogen products (FDP) during pregnancy and after delivery.
    Carozzi S; Molinelli G; Lamperi S
    Panminerva Med; 1977; 19(6):407-13. PubMed ID: 609475
    [No Abstract]   [Full Text] [Related]  

  • 7. [Fibrinogen/fibrin degradation products in the toxemic patient].
    Ahued Ahued JR; Gaviño Ambriz S; Gaviño Gaviño F; Terán Ortiz LM
    Ginecol Obstet Mex; 1985 Apr; 53(336):83-6. PubMed ID: 4029682
    [No Abstract]   [Full Text] [Related]  

  • 8. [Urinary FDP].
    Hashimoto S; Sawa H
    Rinsho Byori; 1983 May; 31(5):480-8. PubMed ID: 6632306
    [No Abstract]   [Full Text] [Related]  

  • 9. [Urinary fibrin/fibrinogen degradation products (FDP) in chronic glomerulonephritis].
    Shimamatsu K
    Fukuoka Igaku Zasshi; 1986 Sep; 77(9):480-9. PubMed ID: 3804170
    [No Abstract]   [Full Text] [Related]  

  • 10. [Determination of fibrin fibrinogen degradation products in urine after kidney allotransplantation].
    Drannik GN; Ena IaM; Glukhen'kaia ZE
    Lab Delo; 1978; (5):266-71. PubMed ID: 79008
    [No Abstract]   [Full Text] [Related]  

  • 11. [Determination of fibrin (fibrinogen) degradation products in urine].
    Andreenko GV; Podorol'skaia LV
    Lab Delo; 1983; (4):35-8. PubMed ID: 6191081
    [No Abstract]   [Full Text] [Related]  

  • 12. [Nephrology in 1975].
    Lagrue G
    Rev Prat; 1975 Nov; 25(53):4137-42, 4145-6, 4151-4 passim. PubMed ID: 1209150
    [No Abstract]   [Full Text] [Related]  

  • 13. [Changes in fibrinogen, fibrin-fibrinogen degradation products and fibrinolytic activity during pregnancy, labor and the puerperium in pregnant women with chronic hypertension].
    Kendić S; Mujezinović O; Muratović H
    Med Arh; 2000; 54(1):29-31. PubMed ID: 10872273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. rHuEPO increases urinary excretion of fibrin degradation products in haemodialysed patients.
    Gareau R; Gagnon MG; Ayotte C; Chénard C; Brisson GR
    Thromb Haemost; 1993 Aug; 70(2):373-4. PubMed ID: 8236152
    [No Abstract]   [Full Text] [Related]  

  • 15. Plasma fibrinogen in pregnancy.
    Stalker AL; Simpson JG; Mackie MJ; Hamlet ME
    J Pathol; 1972 Jan; 106(1):Pix-x. PubMed ID: 5035754
    [No Abstract]   [Full Text] [Related]  

  • 16. Significance of the quantitative determination of "fibrin degradation products" in renal diseases.
    Chin Med J (Engl); 1980 Jul; 93(7):483-6. PubMed ID: 6772396
    [No Abstract]   [Full Text] [Related]  

  • 17. [Urinary cycle in toxemia complications].
    Krystosik J; Krauss A; Piskazeck K
    Gynaecologia; 1968; 166(6):498-502. PubMed ID: 5707028
    [No Abstract]   [Full Text] [Related]  

  • 18. [On the urinary elimination of catecholamines and of their metabolite in toxemia in the 3d trimester of pregnancy].
    Cession G
    Bull Soc R Belge Gynecol Obstet; 1966; 36(3):197-216. PubMed ID: 5914831
    [No Abstract]   [Full Text] [Related]  

  • 19. Coagulation, fibrinolysis, platelet and kinin-forming systems during toxemia of pregnancy.
    Maki M
    Biol Res Pregnancy Perinatol; 1983; 4(4):152-4. PubMed ID: 6652168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Determination of plasma D-dimer in patients with pregnancy induced hypertension].
    Zhou H; Chen R; Liu X
    Zhonghua Fu Chan Ke Za Zhi; 1997 Jun; 32(6):347-9. PubMed ID: 9596914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.